Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment - Eikelboom, J W; O'Donnell, M; Yusuf, S (Am Heart J, 2010)